Bert Jacquemyn

Bert Jacquemyn is a seasoned professional in drug development and program management, currently serving as Senior Director and Program Leader at argenx since October 2019. Prior to this role, Bert held the position of Senior Development Lead in Program Management at Galapagos from February 2018 to September 2019. A significant portion of Bert's career was spent at Janssen, Pharmaceutical Companies of Johnson and Johnson, from 2010 to February 2018, where Bert was involved in R&D program management and regulatory affairs. Additional experience includes leadership roles at Tibotec, where Bert managed project management for research and early development, and a position as Validation Engineer at Innogenetics. Bert's academic background includes an MSc in Health Economics, Policy and Management from The London School of Economics and Political Science, an MSc in Industrial Management from KU Leuven, and an MSc in Applied Biological Sciences with a focus on cellular and gene biotechnology, also from KU Leuven.